AzTrials
AzTrials

Critical IllnessSAUV-IRUNCT07411976

Critical Care Admission Following Emergency Department's Resuscitation Room Care

An observational study of Critical Illness and Emergency Department Patient, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective multicenter observational study aims to describe resuscitation room activity in France and to compare critical care admission within 24 hours between patients directly admitted to the resuscitation room and those admitted secondarily after initial emergency department management. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Emergency resuscitation room management (observational)
How many people
1,629 participants
Where
1 siteFrance
Study dates
1 Apr 2026to 3 Apr 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult patients (≥18 years old) admitted to the resuscitation room of participating emergency departments during the study period. All eligible patients admitted directly or secondarily to the resuscitation room are included consecutively, without intervention assignment. Patients are managed according to usual care and local protocols.

Who may be able to join

  • Adult patients (≥18 years old) admitted to the resuscitation room during the study period.

Who cannot join

  • Patients younger than 18 years.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nîmes

    Nîmes, 30029

Other trials in France

About this study

Official title: SAUV IRU: A Multicenter Prospective Observational Study Describing Resuscitation Room Activity and Comparing Critical Care Admission After Direct vs Secondary Admission

This prospective multicenter observational study aims to describe resuscitation room activity in France and to compare critical care admission within 24 hours between patients directly admitted to the resuscitation room and those admitted secondarily after initial emergency department management. Adult patients admitted to the resuscitation room over a 72-hour period in participating centers will be included. Data collection includes patient characteristics, triage severity, physiological parameters, critical interventions, and outcomes at 24 hours.

Read the detailed description

This is a prospective, multicenter, observational cohort study including all consecutive adult patients admitted to the resuscitation room in participating emergency departments over a predefined 72-hour study period. Patients are categorized according to their mode of admission to the resuscitation room (direct or secondary after initial emergency department management). No intervention is assigned by the study, and patient care follows usual practice and local protocols. Data collection includes patient-level clinical and physiological variables, resuscitation room processes of care, organizational characteristics at the center level, and practitioner-level characteristics. The primary outcome is critical care admission or death within 24 hours after resuscitation room admission.

Statistical analysis Analyses will be conducted in adult patients (≥18 years) admitted to the resuscitation room. Patients will be categorized according to the mode of resuscitation room admission (direct vs secondary).

The primary outcome is critical care admission or death within 24 hours after resuscitation room admission. The primary analysis will compare the proportion of patients meeting the primary outcome between groups using logistic regression, with adjustment for prespecified baseline variables and center effects. Results will be reported as odds ratios with 95% confidence intervals. Secondary and prespecified outcomes will be analyzed descriptively. Missing data will be described and analyses performed on available data.

An ancillary analysis will be conducted among patients who receive blood transfusion during resuscitation room management. This ancillary study will use the same prospective observational dataset and will not involve any additional data collection or modification of patient management. Analyses will focus on patient characteristics, indications for transfusion, transfusion practices, and short-term outcomes.

Being tested
Emergency resuscitation room management (observational)
Keywords
Emergency Department, Resuscitation Room, Critical Care Admission
Medical subject headings
Critical Illness, Shock, Wounds and Injuries, Respiratory Insufficiency, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emergency resuscitation room management (observational)Other

    Patients receive standard emergency care in the resuscitation room according to local protocols and clinician judgment. No intervention is assigned by the study. Clinical management, diagnostic procedures, and therapeutic interventions are recorded for observational purposes only.

Study groups in NCT07411976
Study groupRoleWhat they receive
Direct resuscitation room admissionAdult patients (≥18 years old) admitted directly to the resuscitation room from the prehospital setting or immediately upon arrival at the emergency department, without prior clinical management in another emergency department area.
Receives: Other: Emergency resuscitation room management (observational)
Secondary resuscitation room admissionAdult patients (≥18 years old) admitted to the resuscitation room secondarily, after an initial evaluation or management in another emergency department area (e.g., standard treatment area, waiting area, imaging unit, or other hospital sector), before transfer to the resuscitation room.
Receives: Other: Emergency resuscitation room management (observational)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Critical care admission within 24 hours after resuscitation room admission

    Proportion of patients admitted to critical care (intensive care unit or intermediate care unit) or deceased within 24 hours following admission to the resuscitation room, comparing direct versus secondary resuscitation room admission.

    Measured: Within 24 hours after resuscitation room admission

Secondary outcomes (11)
  1. All-cause mortality within 24 hours

    All-cause mortality occurring within 24 hours after resuscitation room admission.

    Measured: Within 24 hours after resuscitation room admission

  2. Use of critical care interventions in the resuscitation room

    Proportion of patients receiving at least one critical care intervention in the resuscitation room, including airway management, mechanical ventilation or non-invasive ventilation, vasopressor therapy, transfusion, renal replacement therapy, or cardiopulmonary resuscitation.

    Measured: Day 1

  3. Center-level organizational characteristics

    Description of resuscitation room organizational characteristics, including material resources, human resources, and availability of critical care equipment.

    Measured: Baseline (during study period)

  4. Physiological severity at resuscitation room admission-part 1

    Blood pressure at admission

    Measured: Baseline

  5. Physiological severity at resuscitation room admission-part 2

    Heart rate at admission

    Measured: Baseline

  6. Physiological severity at resuscitation room admission-part 3

    Respiratory rate at admission

    Measured: Baseline

  7. Physiological severity at resuscitation room admission-part 4

    Pulsed oxygen saturation at admission

    Measured: Baseline

  8. Physiological severity at resuscitation room admission-part 5

    Temperature at admission

    Measured: Baseline

  9. Physiological severity at resuscitation room admission-part 6

    Glasgow Coma Scale at admission

    Measured: Baseline

  10. Physiological severity at resuscitation room admission-part 7

    Capillary blood glucose at admission

    Measured: Baseline

  11. Physiological severity at resuscitation room admission-part 8

    Capillary blood glucose at admission

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2026
  2. Study start1 Apr 2026
  3. Primary completion3 Apr 2026
  4. Study completion3 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,629 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07411976
Sponsor's protocol ID
IRB CHU Nîmes 25.11.01
Acronym
SAUV-IRU
Status last verified
Jun 2026
First submitted
26 Jan 2026
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because this observational study does not include a data sharing plan and data use is restricted to the objectives defined in the protocol.

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness and Emergency Department Patient, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Critical care admission within 24 hours after resuscitation room admission (time frame: Within 24 hours after resuscitation room admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in